避孕药具市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Contraceptives Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月11日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球避孕药具市场价值为230 亿美元，由于人们越来越重视预防性传染病(STD) 以及对怀孕创新技术的认识不断增强，预计2024 年至2032 年期间复合年增长率将达到6.3%预防。随着公共卫生运动强调安全性行为的重要性，越来越多的人正在寻求有效的避孕方法，以降低性传染病和意外怀孕的风险。此外，避孕技术的进步，例如非侵入性方法和个人化解决方案，正在吸引消费者，进一步促进市场成长，并扩大获得有效避孕选择的机会。整个避孕药具产业根据产品、年龄层、配销通路和地区进行划分。

由于对子宫内避孕器 (IUD) 和植入式避孕器等持久且高效的选择的需求不断增加，2023 年该器械领域的销售额将达到 160 亿美元。这些方法在预防意外怀孕方面的成功率更高，这促使他们比传统替代方法更受青睐。此外，科技的进步和生殖健康意识的提高进一步促进了避孕器具的采用，巩固了与其他形式的避孕器具相比其在市场上的主导地位。在药房、药局和线上平台上产品供应不断增加的推动下，到 2032 年，零售领域将达到 183 亿美元。

便利性，加上消费者对便利访问的偏好，推动了这一领域的成长。零售通路提供多种避孕选择，让消费者可以选择最适合自己需求的产品。此外，促销活动和健康活动正在提高消费者的意识，从而加强零售部门在避孕药具市场中的地位。由于该地区强大的医疗基础设施、较高的计划生育意识以及先进避孕方法的广泛使用，北美避孕药具行业到 2023 年将达到 75 亿美元，到 2032 年复合年增长率将达到 4%。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	230亿美元
预测值	400 亿美元
复合年增长率	6.3%

政府支持生殖健康的倡议，以及人们对长效可逆避孕药 (LARC) 的日益青睐，进一步推动了市场成长。此外，领先製造商和完善的分销网络的存在增强了避孕产品的获取。北美强劲的需求和先进的医疗保健系统使其成为全球避孕药市场的主要贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 已开发国家有利的监管环境
  - 越来越倾向于计划性延迟妊娠
  - 发展中经济体的避孕需求未被满足
  - 性传染病（STD）盛行率不断上升
- 产业陷阱与挑战
  - 避孕药的不良反应
成长潜力分析
监管环境
报销场景
定价趋势
消费者行为分析
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
装置
- 保险套
  - 男性
  - 女性
- 子宫内避孕器
  - 荷尔蒙子宫内避孕器
  - 含铜子宫内避孕器
- 阴道环
- 皮下植入物
- 隔膜
- 避孕海绵
药品
- 口服避孕药
- 注射避孕药
- 外用避孕药

第 6 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
15 - 44 岁
44岁以上

第 7 章：市场估计与预测：按配销通路，2021 - 2032 年

主要趋势
零售药局
医院药房
线上通路
其他分销管道

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Afaxys, Inc.
Agile Therapeutics
Amneal Pharmaceuticals
Bayer AG
Church & Dwight Co., Inc.
Cooper Companies
Evofem Biosciences
HRA Pharma
Maxwellia Ltd
Mayer Laboratories, Inc.
Mithra Pharmaceuticals
Organon & Co.
Pfizer, Inc.
Reckitt Benckiser Group PLC
TherapeuticsMD, Inc.
Veru, Inc.

简介目录

Product Code: 430

The Global Contraceptives Market was valued at USD 23 billion in 2023 and is estimated to expand at a 6.3% CAGR between 2024 and 2032, spurred by the increasing emphasis on the prevention of sexually transmitted diseases (STDs) and growing awareness of innovative technologies for pregnancy prevention. As public health campaigns highlight the importance of safe sexual practices, more individuals are seeking effective contraceptive methods to reduce the risk of STDs and unintended pregnancies. Also, advancements in contraceptive technologies, such as non-invasive methods and personalized solutions, are attracting consumers, further boosting market growth, and broadening access to effective contraceptive options. The overall contraceptives industry is segregated based on product, age group, distribution channel, and region.

The devices segment achieved USD 16 billion in 2023 due to the increasing demand for long-lasting and highly effective options like intrauterine devices (IUDs) and contraceptive implants. These methods offer a higher success rate in preventing unintended pregnancies, which drives their preference over traditional alternatives. Additionally, advancements in technology and growing awareness about reproductive health further boost the adoption of contraceptive devices, solidifying their dominance in the market compared to other forms of contraception. The retail segment will establish USD 18.3 billion by 2032, driven by the increasing availability of products in pharmacies, drugstores, and online platforms.

Convenience, coupled with consumer preference for easy access, drives growth in this segment. Retail channels provide a variety of contraceptive options, allowing consumers to choose products that best suit their needs. Furthermore, promotional activities and health campaigns are enhancing consumer awareness, thereby reinforcing the retail segment's position in the contraceptives market. North America contraceptives industry held a USD 7.5 billion in 2023 and will experience a 4% CAGR through 2032, owing to the region's strong healthcare infrastructure, high awareness of family planning, and widespread use of advanced contraceptive methods.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$23 Billion
Forecast Value	$40 Billion
CAGR	6.3%

Government initiatives supporting reproductive health, along with a growing preference for long-acting reversible contraceptives (LARCs), further propel market growth. Besides, the presence of leading manufacturers and well-established distribution networks enhances access to contraceptive products. North America's robust demand and advanced healthcare system make it the key contributor to the global contraceptives market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Favourable regulatory scenario in developed nations
  - 3.2.1.2 Growing inclination towards planned delayed pregnancy
  - 3.2.1.3 High unmet contraceptive needs in developing economies
  - 3.2.1.4 Growing prevalence of sexually transmitted diseases (STD)
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects of contraceptive drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Pricing trends
3.7 Consumer behavior analysis
3.8 Technology landscape
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Devices
- 5.2.1 Condoms
  - 5.2.1.1 Male
  - 5.2.1.2 Female
- 5.2.2 Intra-uterine devices
  - 5.2.2.1 Hormonal IUD
  - 5.2.2.2 Copper IUD
- 5.2.3 Vaginal rings
- 5.2.4 Subdermal implants
- 5.2.5 Diaphragms
- 5.2.6 Contraceptive sponges
5.3 Drugs
- 5.3.1 Oral contraceptive pills
- 5.3.2 Injectable contraceptives
- 5.3.3 Topical contraceptives

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 15 - 44 years
6.3 Above 44 years

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Retail pharmacies
7.3 Hospital pharmacies
7.4 Online channels
7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa